ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Seer Data On Cancer Incidence Among Minorities Published

May 10, 1996

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990